Skip to content

Kava (Piper methysticum) consumption patterns and conceptualizations: results from an online survey.

Katherine Hill, Cianna Piercey, Hollis C Karoly, Kirsten E Smith

Substance abuse treatment, prevention, and policy May 5, 2026 DOI: 10.1186/s13011-026-00728-3 via PubMed

Summary

Kava, a psychoactive plant from the Pacific Islands, is used for its anxiolytic and sedating effects. In a 2024 online survey of 368 adults who had used kratom, kava, tianeptine, or akuamma seed, 48.9% had used kava in their lifetime. Lifetime kava users were younger, more racially diverse, and more likely to be employed or in school. Kava was purchased online (40.6%) or in tea bars (31.7%). Users reported infrequent consumption (average 4.4 months per year, 9.1 days per month). Perceived effects included reduced general anxiety (33.7%), improved mood (32.9%), reduced social anxiety (25.5%), and sedation (23.4%). Only 11.7% viewed kava as habit-forming, and 51.7% saw it as an alcohol replacement. Kava use practices are diverse, and clinicians should be aware of its role in harm-reduction.

Study at a glance

Characteristics Cross-sectional survey Peer reviewed
Sample size 368
Population Adults aged 18 and older in the United States who endorsed lifetime use of kratom, kava, tianeptine, or akuamma seed
Keywords Piper methysticum Alcohol Harm-reduction Kava Kratom
Key finding Among 368 survey participants, 48.9% had used kava in their lifetime, most viewed it favorably, and 51.7% conceptualized it as an alcohol replacement.

Abstract

'Kava,' or 'kava kava,' (Piper methysticum) is a psychoactive plant indigenous to the Pacific Islands. Historical consumption is reported to provide anxiolytic and sedating effects. In regions where kava is native, it has been used in religious and cultural practices, as well as for medicinal purposes. The mechanisms by which kavalactones - the best studied psychoactive constituent of kava - may mediate pharmacological effects include enhancing the GABAA receptor, blocking of sodium and calcium channels, blocking reuptake of norepinephrine dopamine, and inhibiting MAO-B. In the United States, products containing kava have proliferated in recent years alongside the rise of ethnobotanical tea bars serving kava preparations. Between December-July 2024, an anonymous online survey on legal psychoactive products was conducted using convenience sampling. Eligible individuals had to be ≥ 18 years old and endorse lifetime use of kratom, kava, tianeptine, and/or akuamma seed. Of the 368 participants, almost half (n = 180, 48.9%) had used kava during their lifetime. Those who reported lifetime use of kava were younger on average (p = 0.001), more racially diverse (p = 0.041), and had a higher proportion of being employed or in school (p = 0.012) than those where did not use kava in their lifetime. Kava was purchased online (40.6%) or in ethnobotanical tea bars (31.7%). Many reported infrequent consumption (average = 4.4 months/year and 9.1 days/30 days). Lifetime use of alcohol, kratom, and cannabis was common. Approximately one-third of participants had consumed kava more than 100 times, with commonly reported perceived effects from kava experienced in the minutes and hours after consumption included reduced general anxiety (33.7%), improved mood (32.9%), reduced social anxiety (25.5%), and sedation (23.4%). Most respondents had favorable conceptualizations of kava, with only 11.7% characterizing that kava alone as habit-forming. Many (51.7%) conceptualized kava as an alcohol replacement with 18.3% and 16.7% using kava as a short- and/or long-term substitute for alcohol, respectively. Kava use practices are diverse, though perceived kava effects appear mostly mild. The proliferation and diversification of kava products pre-mixed with other psychoactive botanicals requires study as the benefit-risk profile may change. Clinicians should be aware of kava use for harm-reduction and other purposes.

Comments

No comments yet.

Log in to comment